Accuray | ARAY - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Accuray

Accuray reported $89.06M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Abbott ABT:US USD 9.16B 721M
Accuray ARAY:US USD 89.06M 21.33M
AngioDynamics ANGO:US USD 30.11M 254K
Artivion Inc CRY:US USD 30.77M 8.58M
AtriCure ATRC:US USD 135.86M 77.76M
Edwards Lifesciences EW:US USD 872.5M 103.5M
Hologic HOLX:US USD 2.58B 140.9M
Inogen INGN:US USD 164.14M 22.88M
Mesa Laboratories MLAB:US USD 32.91M 6.81M
Orthofix International OFIX:US USD 49.97M 732K
Surmodics SRDX:US USD 19.18M 7.25M
Tandem Diabetes Care TNDM:US USD 127.76M 44.76M
Trinity Biotech TRIB:US USD 6.58M 676K